Angular Ventures’ investment in Swan Neck Bio

Poul Schmith has advised in connection with Angular Ventures’ investment in Swan Neck Bio. Angular Ventures is a venture capital fund that invests in early-stage technology companies. Swan Neck Bio is a biotechnology company focused on the development of new treatment methods.

Poul Schmith has advised in connection with Angular Ventures’ investment in Swan Neck Bio. Angular Ventures is a venture capital fund that invests in early-stage technology companies. Swan Neck Bio is a biotechnology company focused on the development of new treatment methods.

Angular Ventures is a specialist venture capital firm committed to founders redefining global markets. They prefer to invest in the first institutional round.

Swan Neck Bio provides innovative biosolutions for biomanufacturing, focusing on microbial innovations and starter culture development using their proprietary FlexCell® technology. They help food and biotech innovators unlock reliable, profitable biomanufacturing.

The team behind the transaction was Ronnie Kandler, Patrick Agbemadon and Sebastian Ravn Nielsen.

Newsletter

Get legal knowledge and insights from our experts directly in your inbox.